Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel

Inclusion Criteria: 1. Female sex; 2. Age over 18 years; 3. Caucasian race; 4. Thin, dry, and sagging facial skin; 5. Signing an informed consent form; 6. Commitment to refrain from undergoing facial therapies that may affect skin condition; 7. Negative pregnancy test result and commitment to use a contraceptve method; Exclusion Criteria: 1. Scars, birthmarks, or tattoos on the face that could interfere with the assessment of skin condition; 2. Presence of open wounds, ulcers, active infections, or other significant skin damage at the planned injection site; 3. Receipt of intradermal facial injections with native hyaluronic acid, platelet-rich plasma, or other injectable therapies within 6 months prior to study initiation; 4. Receipt of intradermal facial injections with slowly absorbable or non-absorbable filler products within 12 months prior to study initiation; 5. Known hypersensitivity to any component of the investigational product; 6. Dermatitis or dermatological disease of inflammatory and/or infectious nature at the planned injection site; 7. History of cancer, autoimmune disease, or immunodeficiency; 8. Use of medications affecting blood coagulation; 9. Use of topical antihistamines, corticosteroids, or retinoids on the face within 4 weeks prior to the study; 10. Pregnancy or breastfeeding; 11. Participation or planned participation in other clinical trials;